These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 17566124)
1. A double blind randomized placebo control trial of levetiracetam in Tourette syndrome. Smith-Hicks CL; Bridges DD; Paynter NP; Singer HS Mov Disord; 2007 Sep; 22(12):1764-70. PubMed ID: 17566124 [TBL] [Abstract][Full Text] [Related]
2. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. Hedderick EF; Morris CM; Singer HS Pediatr Neurol; 2009 Jun; 40(6):420-5. PubMed ID: 19433274 [TBL] [Abstract][Full Text] [Related]
3. Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome. Awaad Y; Michon AM; Minarik S Mov Disord; 2005 Jun; 20(6):714-8. PubMed ID: 15704204 [TBL] [Abstract][Full Text] [Related]
4. An open-label, prospective study of levetiracetam in children and adolescents with Tourette syndrome. Fernández-Jaén A; Fernández-Mayoralas DM; Muñoz-Jareño N; Calleja-Pérez B Eur J Paediatr Neurol; 2009 Nov; 13(6):541-5. PubMed ID: 19211282 [TBL] [Abstract][Full Text] [Related]
5. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial. Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J; Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752 [TBL] [Abstract][Full Text] [Related]
6. Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor. Handforth A; Martin FC Mov Disord; 2004 Oct; 19(10):1215-21. PubMed ID: 15390011 [TBL] [Abstract][Full Text] [Related]
7. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study. Wasserman S; Iyengar R; Chaplin WF; Watner D; Waldoks SE; Anagnostou E; Soorya L; Hollander E Int Clin Psychopharmacol; 2006 Nov; 21(6):363-7. PubMed ID: 17012983 [TBL] [Abstract][Full Text] [Related]
8. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B; Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423 [TBL] [Abstract][Full Text] [Related]
9. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study. Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264 [TBL] [Abstract][Full Text] [Related]
10. Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder. Silver AA; Shytle RD; Sheehan KH; Sheehan DV; Ramos A; Sanberg PR J Am Acad Child Adolesc Psychiatry; 2001 Sep; 40(9):1103-10. PubMed ID: 11556635 [TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder. Nicolson R; Craven-Thuss B; Smith J; McKinlay BD; Castellanos FX J Am Acad Child Adolesc Psychiatry; 2005 Jul; 44(7):640-6. PubMed ID: 15968232 [TBL] [Abstract][Full Text] [Related]
12. Levetiracetam in the treatment of antipsychotics-resistant Tourette syndrome. Oulis P; Karapoulios E; Masdrakis VG; Kouzoupis AV; Karakatsanis NA; Papageorgiou C; Papadimitriou GN; Soldatos CR World J Biol Psychiatry; 2008; 9(1):76-7. PubMed ID: 17853302 [TBL] [Abstract][Full Text] [Related]
13. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial. Müller-Vahl KR; Schneider U; Koblenz A; Jöbges M; Kolbe H; Daldrup T; Emrich HM Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146 [TBL] [Abstract][Full Text] [Related]
14. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures. Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175 [TBL] [Abstract][Full Text] [Related]
15. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study. Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011 [TBL] [Abstract][Full Text] [Related]
16. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies. Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of Glutamate Modulators in Tic Suppression: A Double-Blind, Randomized Control Trial of D-serine and Riluzole in Tourette Syndrome. Lemmon ME; Grados M; Kline T; Thompson CB; Ali SF; Singer HS Pediatr Neurol; 2015 Jun; 52(6):629-34. PubMed ID: 26002052 [TBL] [Abstract][Full Text] [Related]
18. The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial. Holbech JV; Otto M; Bach FW; Jensen TS; Sindrup SH Eur J Pain; 2011 Jul; 15(6):608-14. PubMed ID: 21183370 [TBL] [Abstract][Full Text] [Related]
19. Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders. Du YS; Li HF; Vance A; Zhong YQ; Jiao FY; Wang HM; Wang MJ; Su LY; Yu DL; Ma SW; Wu JB Aust N Z J Psychiatry; 2008 Sep; 42(9):807-13. PubMed ID: 18696285 [TBL] [Abstract][Full Text] [Related]